Clinical Trials
33 trialsCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
iCaRe2
University of Nebraska
DP-04
AstraZeneca
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Memorial Sloan Kettering Cancer Center
ICI-PICK
Indiana University
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
YASU Research Registry: For Young Adults With Cancer
Young Adult Survivors United
Using QPOP to Predict Treatment for Sarcomas and Melanomas
National Cancer Centre, Singapore
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Region Skane
PREFER
Labcorp Corporation of America Holdings, Inc
EVIDENT
Sheffield Teaching Hospitals NHS Foundation Trust
BEGIN
BostonGene
ROOT
Taproot Health
REGATA
N.N. Petrov National Medical Research Center of Oncology
Retinoblastoma Biomarker Study
National Institutes of Health Clinical Center (CC)
HSP70CTC
Charite University, Berlin, Germany
PIONEER
SpeciCare
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
MMS-TM
MedInnovation GmbH
CTC
Comprehensive Cancer Centers of Nevada
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
Royal Marsden NHS Foundation Trust
Assessing the Patient Experience in Cancer Care
Mayo Clinic
B-Receptor Signaling in Cardiomyopathy
Stanford University
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
M.D. Anderson Cancer Center
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
National Cancer Institute (NCI)